Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Cairncross, K. Ueki, Magdelena Zlatescu, D. Lisle, D. Finkelstein, R. Hammond, J. Silver, P. Stark, D. MacDonald, Y. Ino, D. Ramsay, D. Louis (1998)
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.Journal of the National Cancer Institute, 90 19
M. Rossi, Jeffrey Duca, S. Matsui, N. Nowak, L. Hawthorn, J. Cowell (2005)
Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiformeGenes, 44
P. Roerig, M. Nessling, B. Radlwimmer, S. Joos, G. Wrobel, C. Schwaenen, G. Reifenberger, P. Lichter (2005)
Molecular classification of human gliomas using matrix‐based comparative genomic hybridizationInternational Journal of Cancer, 117
P. Hupé, Nicolas Stransky, J. Thiery, F. Radvanyi, E. Barillot (2004)
Analysis of array CGH data: from signal ratio to gain and loss of DNA regionsBioinformatics, 20 18
A. Misra, M. Pellarin, J. Nigro, I. Smirnov, D. Moore, K. Lamborn, D. Pinkel, D. Albertson, B. Feuerstein (2005)
Array Comparative Genomic Hybridization Identifies Genetic Subgroups in Grade 4 Human AstrocytomaClinical Cancer Research, 11
R. Stupp, Warren Mason, M. Bent, M. Weller, B. Fisher, M. Taphoorn, K. Bélanger, A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, Robert Janzer, Samuel Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. Cairncross, E. Eisenhauer, R. Mirimanoff (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.The New England journal of medicine, 352 10
K. Hoang-Xuan, J. He, S. Huguet, K. Mokhtari, Y. Marie, M. Kujas, P. Leuraud, L. Capelle, J. Delattre, J. Poirier, P. Broët, M. Sanson (2001)
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progressionNeurology, 57
H. Ohgaki, P. Kleihues (2007)
Genetic pathways to primary and secondary glioblastoma.The American journal of pathology, 170 5
Justin Smith, A. Perry, T. Borell, Hyun Lee, J. O'fallon, Sandra Hosek, D. Kimmel, A. Yates, P. Burger, B. Scheithauer, R. Jenkins (2000)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 3
C. Griffin, P. Burger, L. Morsberger, R. Yonescu, Sharon Swierczynski, J. Weingart, K. Murphy (2006)
Identification of der(1;19)(q10;p10) in Five Oligodendrogliomas Suggests Mechanism of Concurrent 1p and 19q LossJournal of Neuropathology and Experimental Neurology, 65
J. Cowell, G. Barnett, N. Nowak (2004)
Characterization of the 1p/19q Chromosomal Loss in Oligodendrogliomas Using Comparative Genomic Hybridization Arrays (CGHa)JNEN: Journal of Neuropathology & Experimental Neurology, 63
C. Giannini, B. Scheithauer, A. Weaver, P. Burger, J. Kros, S. Mørk, M. Graeber, S. Bauserman, J. Buckner, James Burton, R. Riepe, H. Tazelaar, A. Nascimento, T. Crotty, G. Keeney, P. Pernicone, H. Altermatt (2001)
Oligodendrogliomas: Reproducibility and Prognostic Value of Histologic Diagnosis and GradingJNEN: Journal of Neuropathology & Experimental Neurology, 60
P. Neuvial, P. Hupé, I. Brito, S. Liva, Elodie Manié, Caroline Brennetot, F. Radvanyi, A. Aurias, E. Barillot (2006)
Spatial normalization of array-CGH dataBMC Bioinformatics, 7
S. Coons, P. Johnson, B. Scheithauer, A. Yates, D. Pearl (1997)
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomasCancer, 79
M. Sanson, J. Thillet, K. Hoang-Xuan (2004)
Molecular changes in gliomasCurrent Opinion in Oncology, 16
P. Rosa, E. Viara, P. Hupé, G. Pierron, S. Liva, P. Neuvial, I. Brito, S. Lair, N. Servant, N. Robine, Elodie Manié, Caroline Brennetot, I. Janoueix-Lerosey, V. Raynal, N. Gruel, C. Rouveirol, Nicolas Stransky, M. Stern, O. Delattre, A. Aurias, F. Radvanyi, E. Barillot (2006)
VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profilesBioinformatics, 22 17
J. He, K. Mokhtari, M. Sanson, Y. Marie, M. Kujas, S. Huguet, P. Leuraud, L. Capelle, J. Delattre, J. Poirier, K. Hoang-Xuan (2001)
Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular StudyJNEN: Journal of Neuropathology & Experimental Neurology, 60
Yuri Kotliarov, M. Steed, Neil Christopher, Jennifer Walling, Q. Su, A. Center, John Heiss, M. Rosenblum, T. Mikkelsen, J. Zenklusen, H. Fine (2006)
High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.Cancer research, 66 19
Q. Hu, B. Ang, M. Karsak, Weiping Hu, X. Cui, Tanya Duka, Y. Takeda, W. Chia, N. Sankar, Y. Ng, E. Ling, T. Maciag, D. Small, Radianna Trifonova, Raphael Kopan, H. Okano, M. Nakafuku, S. Chiba, H. Hirai, J. Aster, M. Schachner, C. Pallen, Kazutada Watanabe, Zhi-Cheng Xiao (2003)
F3/Contactin Acts as a Functional Ligand for Notch during Oligodendrocyte MaturationCell, 115
J. Cairncross, D. Macdonald (1990)
Oligodendroglioma: a new chemosensitive tumor.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 8 12
M. Kenward (2007)
An Introduction to the Bootstrap
K. Ichimura, A. Mungall, H. Fiegler, D. Pearson, I. Dunham, N. Carter, V. Collins (2006)
Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGHOncogene, 25
H. Ohgaki, P. Kleihues (2005)
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.Journal of neuropathology and experimental neurology, 64 6
Xing Fan, I. Mikolaenko, Ihab Elhassan, Xingzhi Ni, Yunyue Wang, D. Ball, D. Brat, A. Perry, C. Eberhart (2004)
Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor GrowthCancer Research, 64
K. Hess, K. Broglio, M. Bondy (2004)
Adult glioma incidence trends in the United States, 1977–2000Cancer, 101
A. Rasheed, J. Herndon, T. Stenzel, Jacqueline Raetz, Jason Kendelhardt, H. Friedman, A. Friedman, D. Bigner, S. Bigner, R. McLendon (2002)
Molecular markers of prognosis in astrocytic tumorsCancer, 94
Markus Bredel, C. Bredel, Dejan Juric, G. Harsh, Hannes Vogel, Lawrence Recht, B. Sikic (2005)
High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.Cancer research, 65 10
J. Oertel, Ekaterina Buttlar, H. Schroeder, M. Gaab (2005)
Prognosis of gliomas in the 1970s and today.Neurosurgical focus, 18 4
S. Daido, S. Takao, T. Tamiya, Y. Ono, K. Terada, Sachio Ito, M. Ouchida, I. Date, T. Ohmoto, K. Shimizu (2004)
Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.Oncology reports, 12 4
David Jones, K. Ichimura, Lu Liu, D. Pearson, Karen Plant, V. Collins (2006)
Genomic Analysis of Pilocytic Astrocytomas at 0.97 Mb Resolution Shows an Increasing Tendency Toward Chromosomal Copy Number Change With AgeJournal of Neuropathology and Experimental Neurology, 65
G. Kitange, A. Misra, M. Law, S. Passe, T. Kollmeyer, M. Maurer, K. Ballman, B. Feuerstein, R. Jenkins (2005)
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomasGenes, 42
M. Rossi, D. Gaile, J. Laduca, S. Matsui, J. Conroy, D. McQuaid, D. Chervinsky, R. Eddy, Hailei Chen, G. Barnett, N. Nowak, J. Cowell (2005)
Identification of consistent novel submegabase deletions in low‐grade oligodendrogliomas using array‐based comparative genomic hybridizationGenes, 44
H. Phillips, S. Kharbanda, Ruihuan Chen, W. Forrest, R. Soriano, Thomas Wu, A. Misra, J. Nigro, H. Colman, L. Soroceanu, P. Williams, Z. Modrušan, B. Feuerstein, K. Aldape (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer cell, 9 3
P. Kleihues, D. Louis, B. Scheithauer, L. Rorke, G. Reifenberger, P. Burger, W. Cavenee (2002)
The WHO Classification of Tumors of the Nervous SystemJNEN: Journal of Neuropathology & Experimental Neurology, 61
J. Cowell, S. Matsui, Y. Wang, J. Laduca, J. Conroy, D. McQuaid, N. Nowak (2004)
Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme.Cancer genetics and cytogenetics, 151 1
A. Idbaih, Y. Marie, G. Pierron, Caroline Brennetot, K. Hoang-Xuan, M. Kujas, K. Mokhtari, M. Sanson, J. Lejeune, A. Aurias, O. Delattre, J. Delattre (2005)
Two types of chromosome 1p losses with opposite significance in gliomasAnnals of Neurology, 58
D. Louis, E. Holland, J. Cairncross (2001)
Glioma classification: a molecular reappraisal.The American journal of pathology, 159 3
E. Maher, C. Brennan, P. Wen, Laura Durso, K. Ligon, Aaron Richardson, D. Khatry, Bin Feng, Raktim Sinha, D. Louis, John Quackenbush, P. Black, L. Chin, R. DePinho (2006)
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.Cancer research, 66 23
A. Hui, K. Lo, Xiao-lu Yin, W. Poon, H. Ng (2001)
Detection of Multiple Gene Amplifications in Glioblastoma Multiforme Using Array-Based Comparative Genomic HybridizationLaboratory Investigation, 81
K. Ueki, R. Nishikawa, Y. Nakazato, T. Hirose, J. Hirato, N. Funada, T. Fujimaki, S. Hojo, O. Kubo, T. Ide, M. Usui, Chikayuki Ochiai, S. Ito, Hiroshi Takahashi, A. Mukasa, A. Asai, T. Kirino (2002)
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 1
R. Jenkins, H. Blair, K. Ballman, C. Giannini, R. Arusell, M. Law, H. Flynn, S. Passe, Sara Felten, P. Brown, E. Shaw, J. Buckner (2006)
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.Cancer research, 66 20
K. Fallon, C. Palmer, K. Roth, Wenquan Wang, M. Carpenter, Ruma Banerjee, P. Forsyth, K. Rich, A. Perry (2004)
Prognostic Value of 1p, 19q, 9p, 10q, and EGFR‐FISH Analyses in Recurrent OligodendrogliomasJNEN: Journal of Neuropathology & Experimental Neurology, 63
G. Mohapatra, R. Betensky, Ezra Miller, Bjorn Carey, Leah Gaumont, D. Engler, D. Louis (2006)
Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization.The Journal of molecular diagnostics : JMD, 8 2
M. Mittler, B. Walters, E. Stopa (1996)
Observer reliability in histological grading of astrocytoma stereotactic biopsies.Journal of neurosurgery, 85 6
Debashis Kushary (2000)
Bootstrap Methods and Their ApplicationTechnometrics, 42
M. Kujas, J. Lejeune, A. Benouaich‐Amiel, E. Crinière, F. Laigle-Donadey, Y. Marie, K. Mokhtari, M. Polivka, M. Bernier, F. Chrétien, A. Couvelard, L. Capelle, H. Duffau, P. Cornu, P. Broët, J. Thillet, A. Carpentier, M. Sanson, K. Hoang-Xuan, J. Delattre (2005)
Chromosome 1p loss: A favorable prognostic factor in low‐grade gliomasAnnals of Neurology, 58
Kleihues (2002)
The WHO classification of tumors of the nervous systemJ Neuropathol Exp Neurol, 61
R. Prayson, D. Agamanolis, M. Cohen, M. Estes, B. Kleinschmidt-DeMasters, F. Abdul-Karim, S. McClure, B. Sebek, Robin Vinay (2000)
Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma gradingJournal of the Neurological Sciences, 175
The pathological classification of gliomas constitutes a critical step of the clinical management of patients, yet it is frequently challenging. To assess the relationship between genetic abnormalities and clinicopathological characteristics, we have performed a genetic and clinical analysis of a series of gliomas. A total of 112 gliomas were analyzed by comparative genomic hybridization on a BAC array with a 1 megabase resolution. Altered regions were identified and correlation analysis enabled to retrieve significant associations and exclusions. Whole chromosomes (chrs) 1p and 19q losses with centromeric breakpoints and EGFR high level amplification were found to be mutually exclusive, permitting identification of 3 distinct, nonoverlapping groups of tumors with striking clinicopathological differences. Type A tumors with chrs 1p and 19q codeletion exhibited an oligodendroglial phenotype and a longer patient survival. Type B tumors were characterized by EGFR amplification. They harbored a WHO high grade of malignancy and a short patient survival. Finally, type C tumors displayed none of the previous patterns but the presence of chr 7 gain, chr 9p deletion and/or chr 10 loss. It included astrocytic tumors in patients younger than in type B and whose prognosis was highly dependent upon the number of alterations. A multivariate analysis based on a Cox model shows that age, WHO grade and genomic type provide complementary prognostic informations. Finally, our results highlight the potential of a whole‐genome analysis as an additional diagnostic in cases of unclear conventional genetic findings. © 2007 Wiley‐Liss, Inc.
International Journal of Cancer – Wiley
Published: Mar 15, 2009
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.